Although the insulinotropic effect of GIP is diminished in patients with type 2 diabetes, studies have found that GIP receptor agonists can induce a degree of weight loss and, when used in combination with GLP-1, can produce synergistic effects, enhancing blood glucose reduction and weight loss
Adults who have obesity or at least one weight-related medical condition, like high blood pressure or high cholesterol, may qualify
Without adequate protein, a significant portion of your weight loss comes from muscle rather than fat
Heres what youll find ahead: A plain-English explanation of why GLP-1 medications can cause constipation
S.Fernndez-RojasB.Len-ContrerasJ
The cost savings are significant: compounded semaglutide at $149 to $397 per month versus $1,000+ for brand-name Wegovy